Back
Editas Medicine, Inc. Vs. Lemonade, Inc. Industry Stock Comparison
Sell
21
EDIT
Editas Medicine, Inc.
Last Price:
$2.35
Seasonality Move:
-10.7%
Buy
56
LMND
Lemonade, Inc.
Last Price:
$82.61
Seasonality Move:
-17.4%
Sell
21
Editas Medicine, Inc. (EDIT)
is a Sell
Is Editas Medicine, Inc. a Buy, Sell or Hold?
-
The current Editas Medicine, Inc. [EDIT] share price is $2.34. The Score for EDIT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Lemonade, Inc. (LMND)
is a Buy
Is Lemonade, Inc. a Buy, Sell or Hold?
-
The current Lemonade, Inc. [LMND] share price is $82.61. The Score for LMND is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
LMND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EDIT Stock Price Chart
What is Editas Medicine, Inc.'s stock price today?
-
The Editas Medicine, Inc. share price today is $2.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
LMND Stock Price Chart
What is Lemonade, Inc.'s stock price today?
-
The Lemonade, Inc. share price today is $82.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LMND is experiencing slight buying pressure.
EDIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 40.83 | Sell |
| Chaikin Money Flow: | -2481206 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.32 - 2.56) | Sell |
| Bollinger Bands (100): | (2.36 - 3.4) | Sell |
LMND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.53 | Buy |
| Relative Strength Index (14 RSI): | 60.33 | Buy |
| Chaikin Money Flow: | 385744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.8 - 80.22) | Buy |
| Bollinger Bands (100): | (48.89 - 71.95) | Buy |
EDIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.46 | Sell |
| 20-day SMA: | 2.41 | Sell |
| 50-day SMA: | 2.85 | Sell |
| 200-day SMA: | 2.37 | Sell |
| 8-day EMA: | 2.41 | Sell |
| 20-day EMA: | 2.46 | Sell |
| 50-day EMA: | 2.39 | Sell |
| 200-day EMA: | 1.25 | Buy |
LMND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.9 | Buy |
| 20-day SMA: | 77.12 | Buy |
| 50-day SMA: | 67.78 | Buy |
| 200-day SMA: | 47.72 | Buy |
| 8-day EMA: | 80.12 | Buy |
| 20-day EMA: | 77.1 | Buy |
| 50-day EMA: | 70.11 | Buy |
| 200-day EMA: | 52.2 | Buy |
Editas Medicine, Inc. Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.89 per share.
Lemonade, Inc. Earnings Growth & LMND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.87 per share.
Editas Medicine, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lemonade, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||